1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 Body Contouring Overview 6
3 Products under Development 7
3.1 Body Contouring - Pipeline Products by Stage of Development 7
3.2 Body Contouring - Pipeline Products by Territory 8
3.3 Body Contouring - Pipeline Products by Regulatory Path 9
3.4 Body Contouring - Pipeline Products by Estimated Approval Date 10
4 Body Contouring - Pipeline Products under Development by Companies 11
4.1 Body Contouring Companies - Pipeline Products by Stage of Development 11
4.2 Body Contouring - Pipeline Products by Stage of Development 12
5 Body Contouring Companies and Product Overview 13
5.1 Andrew Technology LLC Company Overview 13
5.1.1 Andrew Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Biosculpture Technology, Inc. Company Overview 15
5.2.1 Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 NivaSonix, LLC Company Overview 17
5.3.1 NivaSonix, LLC Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Slender Medical Ltd. Company Overview 18
5.4.1 Slender Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 Zeltiq Aesthetics Inc Company Overview 19
5.5.1 Zeltiq Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 19
6 Body Contouring- Recent Developments 22
6.1 Mar 03, 2017: ZELTIQ Showcases CoolAdvantage Petite Applicator for the CoolSculpting System at American Academy of Dermatology Annual Meeting 22
6.2 Mar 01, 2017: Syneron Candela Showcases UltraShape Power System at the 2017 American Academy of Dermatology (AAD) Annual Meeting 22
6.3 Mar 01, 2017: ZELTIQ Announces Fourth Quarter and Full Year 2016 Financial Results 23
6.4 Feb 28, 2017: Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance 24
6.5 Feb 15, 2017: Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million 28
6.6 Feb 13, 2017: Allergan to Acquire Zeltiq Aesthetics for USD2.48 Billion 29
6.7 Feb 13, 2017: Cutera Reports Fourth Quarter and Full-Year 2016 Record Revenue and Financial Results 29
6.8 Jan 31, 2017: Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer 30
6.9 Jan 26, 2017: CoolSculpting Announces Only FDA-Cleared Non-Invasive Treatment for Upper Arm Fat 31
6.10 Jan 09, 2017: ZELTIQ Reports Preliminary Fourth Quarter and Full Year 2016 Revenue and Provides 2017 Guidance 32
6.11 Jan 09, 2017: ZELTIQ Aesthetics Announces Commercial Leadership Transition 33
6.12 Jan 09, 2017: Cutera Names James A. Reinstein as its Next President and CEO 34
6.13 Jan 09, 2017: Cutera Announces Record Revenue and Preliminary Financial Results for Fourth Quarter and Full Year 2016 35
6.14 Jan 04, 2017: Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors 35
6.15 Dec 29, 2016: Cytori Therapeutics Plans to Raise Funds through Public Offering of Shares 36
6.16 Dec 28, 2016: Ronald Martell to Join Cytori Therapeutics’ Board of Directors 36
6.17 Dec 22, 2016: Cytori Therapeutics to Raise up to USD20 Million in Private Placement of Shares 36
6.18 Dec 14, 2016: NJ Plastic Surgeon Presents on Fat Transfer Using the HyrdaSolve Lipoplasty System at IFATS San Diego 2016 37
6.19 Dec 12, 2016: Valeant Appoints William D. Humphries As EVP, Dermatology 37
6.20 Nov 29, 2016: Lutronic Raises USD43.7 Million in Rights Offering of Preferred Shares 38
6.21 Nov 14, 2016: Andrew Technologies to Feature Two Powerful New Studies at IFATS San Diego 2016 39
6.22 Nov 09, 2016: ZELTIQ Announces Third Quarter 2016 Financial Results 40
6.23 Nov 09, 2016: Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million 41
6.24 Nov 09, 2016: Cytori Reports Third Quarter 2016 Business and Financial Results 42
6.25 Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results 43
6.26 Nov 07, 2016: Cutera Reports Record Third Quarter 2016 Results 46
6.27 Nov 03, 2016: Cutera Elects J. Daniel Plants as Chairman of the Board 47
6.28 Oct 26, 2016: Clarity Skin First In Utah To Offer Breakthrough, FDA-Cleared, Non-Invasive, UltraShape Power System For Fat Destruction 47
6.29 Oct 26, 2016: Center City Dermatology First In Center City Philadelphia To Offer Breakthrough, FDA-Cleared, Non-Invasive, UltraShape Power System For Fat Destruction 48
6.30 Oct 25, 2016: First MedSpa in Dallas-Fort Worth to Offer Breakthrough, FDA-cleared, Non-Invasive, UltraShape Power System For Fat Destruction 49
6.31 Oct 17, 2016: Syneron Medical Strengthens Senior Management Team 49
6.32 Oct 17, 2016: Syneron Medical Announces Preliminary Third Quarter 2016 Revenue 50
6.33 Oct 17, 2016: Andrew Technologies Announces World’s First Successful Mesenteric Fat Extraction, a Long-Awaited Breakthrough for Potential Reversal of Diabetes 50
6.34 Oct 12, 2016: Clarkston Dermatology First In Michigan To Offer Breakthrough, FDA-Cleared, Non- Invasive, UltraShape Power System For Fat Destruction 51
6.35 Oct 11, 2016: Cutera Announces Preliminary Record Third Quarter 2016 Revenue 52
6.36 Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer 52
6.37 Oct 04, 2016: LaserMed Skin & Vein Clinic First In Southeast To Offer Breakthrough, FDA-Cleared, Non-Invasive, UltraShape Power System For Fat Destruction 53
6.38 Sep 19, 2016: Two New Studies Demonstrate Advantages of Andrew Technologies’ HydraSolve as the Company Heads to ASPS 2016 54
6.39 Aug 22, 2016: Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer 55
6.40 Aug 18, 2016: Cutera Announces Management Changes 56
6.41 Aug 10, 2016: Valeant Pharmaceuticals Comments On SDNY Investigation 56
6.42 Aug 09, 2016: Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results 56
6.43 Aug 08, 2016: Valeant Pharmaceuticals Announces Changes To Executive Management Team 58
6.44 Aug 08, 2016: ZELTIQ Announces Second Quarter 2016 Financial Results 60
6.45 Aug 04, 2016: Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09 61
6.46 Aug 04, 2016: Cytori Reports Second Quarter 2016 Business and Financial Results 63
6.47 Aug 01, 2016: Cutera Reports Second Quarter 2016 Results 64
6.48 Jul 28, 2016: Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors 65
6.49 Jul 18, 2016: Syneron Candela Announces FDA Clearance of High Energy UltraShape Power for Fat Destruction 66
6.50 Jun 27, 2016: ZELTIQ Announces Global Commercial Launch of the CoolAdvantage Applicator for the CoolSculpting System 67
6.51 Jun 17, 2016: Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations 68
6.52 Jun 15, 2016: Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director 68
6.53 Jun 07, 2016: Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results 69
6.54 May 26, 2016: Valeant Pharma Rejects Joint Takeover Bid from Takeda Pharma and TPG Capital Management 70
6.55 May 26, 2016: Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller 70
6.56 May 19, 2016: Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million 71
6.57 May 16, 2016: Valeant Pharmaceuticals Provides Update on Regulatory Matters 72
6.58 May 10, 2016: Cytori Reports First Quarter 2016 Business and Financial Results 73
6.59 May 10, 2016: ZELTIQ Announces First Quarter 2016 Financial Results 74
6.60 Mar 31, 2016: Alma Lasers to Launch Accent Prime, a Cutting-Edge Platform which Doubles the Speed of Body Contouring and Skin Tightening Treatments 76
7 Appendix 77
7.1 Methodology 77
7.2 About GlobalData 80
7.3 Contact Us 80
7.4 Disclaimer 80

1.1 List of Tables
Table 1: Body Contouring - Pipeline Products by Stage of Development 7
Table 2: Body Contouring - Pipeline Products by Territory 8
Table 3: Body Contouring - Pipeline Products by Regulatory Path 9
Table 4: Body Contouring - Pipeline Products by Estimated Approval Date 10
Table 5: Body Contouring Companies - Pipeline Products by Stage of Development 11
Table 6: Body Contouring - Pipeline Products by Stage of Development 12
Table 7: Andrew Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 13
Table 8: HydraSolve Lipoplasty System - Visceral Fat - Product Status 13
Table 9: HydraSolve Lipoplasty System - Visceral Fat - Product Description 14
Table 10: Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 11: Airbrush Liposculptor IIE - Product Status 15
Table 12: Airbrush Liposculptor IIE - Product Description 15
Table 13: Airbrush Liposculptor IIIE - Product Status 16
Table 14: Airbrush Liposculptor IIIE - Product Description 16
Table 15: NivaSonix, LLC Pipeline Products & Ongoing Clinical Trials Overview 17
Table 16: NivaSonix ULLISYS - Product Status 17
Table 17: NivaSonix ULLISYS - Product Description 17
Table 18: Slender Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 18
Table 19: Ultrasound Body Shaping Device - Product Status 18
Table 20: Ultrasound Body Shaping Device - Product Description 18
Table 21: Zeltiq Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 22: CoolAdhesive Gelpad - Product Status 19
Table 23: CoolAdhesive Gelpad - Product Description 20
Table 24: CoolAdvantage Petite Applicator - Product Status 20
Table 25: CoolAdvantage Petite Applicator - Product Description 20
Table 26: Zeltiq Applicator - Cellulite - Product Status 21
Table 27: Zeltiq Applicator - Cellulite - Product Description 21
Table 28: Glossary 79

1.2 List of Figures
Figure 1: Body Contouring - Pipeline Products by Stage of Development 7
Figure 2: Body Contouring - Pipeline Products by Territory 8
Figure 3: Body Contouring - Pipeline Products by Regulatory Path 9
Figure 4: Body Contouring - Pipeline Products by Estimated Approval Date 10